Table 7 Heterogeneity results by Cochran’s Q test of CD25hi %CD4 + and HVEM on CM CD4 + /naive CD4 + /EM CD4 + /CD45RA-CD4 + /CM CD8br on Guillain–barre syndrome.

From: Causal role of the pyrimidine deoxyribonucleoside degradation superpathway mediation in Guillain-Barré Syndrome via the HVEM on CD4 + and CD8 + T cells

Exposures

Outcomes

Cochran’s Q test

Heterogeneity p-value

CD25hi %CD4 + 

Guillain–barre syndrome

IVW

0.619486138

MR Egger

0.604086811

HVEM on CM CD4 + 

IVW

0.594139732

MR Egger

0.6232625

HVEM on naive CD4 + 

IVW

0.719970361

MR Egger

0.710469729

HVEM on EM CD4 + 

IVW

0.077815648

MR Egger

0.058520135

HVEM on CD45RA-CD4 + 

IVW

0.136735097

MR Egger

0.112185987

HVEM on CM CD8br

IVW

0.429305873

MR Egger

0.362362838

  1. HVEM: herpesvirus entry mediator.